Charles Peterfy

17.5k total citations · 6 hit papers
174 papers, 12.7k citations indexed

About

Charles Peterfy is a scholar working on Rheumatology, Surgery and Orthopedics and Sports Medicine. According to data from OpenAlex, Charles Peterfy has authored 174 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Rheumatology, 44 papers in Surgery and 38 papers in Orthopedics and Sports Medicine. Recurrent topics in Charles Peterfy's work include Rheumatoid Arthritis Research and Therapies (110 papers), Musculoskeletal synovial abnormalities and treatments (49 papers) and Osteoarthritis Treatment and Mechanisms (45 papers). Charles Peterfy is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (110 papers), Musculoskeletal synovial abnormalities and treatments (49 papers) and Osteoarthritis Treatment and Mechanisms (45 papers). Charles Peterfy collaborates with scholars based in United States, United Kingdom and Germany. Charles Peterfy's co-authors include Harry K. Genant, Philip G. Conaghan, Paul Emery, Ali Guermazi, Michael C. Nevitt, Philip O’Connor, Erika Schneider, P F Tirman, Mikkel Østergaard and S. Zaïm and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Charles Peterfy

173 papers receiving 12.4k citations

Hit Papers

Whole-Organ Magnetic Resonance Imaging Score (WORMS) of t... 2003 2026 2010 2018 2003 2003 2008 2008 2006 400 800 1.2k

Peers

Charles Peterfy
Comparison fields: 5 of 153
  • Rheumatology 10.4k
  • Surgery 4.1k
  • Biomedical Engineering 2.0k
  • Hematology 2.0k
  • Orthopedics and Sports Medicine 1.9k
Replace Kay‐Geert Hermann with:
Kay‐Geert Hermann Germany
Mario Maas Netherlands
Espen A. Haavardsholm Norway
Fredrick M. Wigley United States
M. Reijnierse Netherlands
Jürgen Rech Germany
Saara Tötterman United States
Thomas M. Link United States
Daniel P. Judge United States
Christopher P. Denton United Kingdom
Kay‐Geert Hermann Germany View profile →
Citations per field, relative to Charles Peterfy
Charles Peterfy · 1×
Citations per year, relative to Charles Peterfy
Charles Peterfy · 1×

Countries citing papers authored by Charles Peterfy

Since Specialization
Citations

This map shows the geographic impact of Charles Peterfy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Peterfy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Peterfy more than expected).

Fields of papers citing papers by Charles Peterfy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Peterfy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Peterfy. The network helps show where Charles Peterfy may publish in the future.

Co-authorship network of co-authors of Charles Peterfy

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Peterfy. A scholar is included among the top collaborators of Charles Peterfy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Peterfy. Charles Peterfy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 130
3 5
4 132
5 15
6 23
7
Sustained Improvements in Magnetic Resonance Imaging Outcomes with Abatacept Following the Withdrawal of All Treatment in Patients with Early Rheumatoid Arthritis
2
8
Rituximab (RTX) plus Methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score)
16
9 67
10 79
11
Reduced Radiographic Progression in Patients with Early Rheumatoid Arthritis (RA) Treated with Abatacept plus Methotrexate Compared to Methotrexate Alone: 24 Month Outcomes
2
12
Disease Remission is Achieved Within Two Years In Over Half of Methotrexate Naive Patients with Early Erosive Rheumatoid Arthritis (RA) Treated with Abatacept Plus MTX: Results from The AGREE Trial
5
13 148
14
The efficacy and safety of abatacept in methotrexate-naive patients with early erosive rheumatoid arthritis and poor prognostic factors
25
15
The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee breakdown →
556
16 312
17 74
18
Reproducibility of the semiflexed (metatarsophalangeal) radiographic knee position and automated measurements of medial tibiofemoral joint space width in a multicenter clinical trial of knee osteoarthritis.
60
19
Knee joint cartilage topography, thickness and contact areas: Validation of measurements from MRI
3
20 146

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026